Mode
Text Size
Log in / Sign up
N/A N=36 Randomized Single-blind Treatment

Treatment Intensity - Apraxia of Speech

Aphasia · CVA · Apraxia of Speech

Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcome: Primary: Accuracy of Articulation of TREATED ITEMS Measured as Effect Size - Change From Baseline to End of Treatment Phase — 19.7; 28.9 effect sizes; magnitude of change — p=.0128

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Sound Production Treatment (SPT) (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Oct 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Accuracy of Articulation of TREATED ITEMS Measured as Effect Size - Change From Baseline to End of Treatment Phase
19.7; 28.9 .0128 sig
PRIMARY
Accuracy of Articulation of Untreated Items (Generalization) Measured as Effect Size - Change From Baseline to End of Treatment Phase
7.9; 8.1 .942
SECONDARY
Speech Intelligibility - Percent Intelligible Words Comparing Baseline to End of Treatment Phases
45.15; 46.15; 48.96; 54.3; 61.5; 60.5 <.001 sig

Summary

A growing neurorehabilitation literature suggests that intense treatment may be desired to maximize the effects of therapy following neurologic injury. This investigation is designed to facilitate the development of efficacious, clinically applicable treatment for acquired apraxia of speech by examining the effects of intensity of treatment (e.g., 9 hours per week vs. 3 hours per week, while holding total number of sessions constant) with a group of speakers who have chronic apraxia of speech and aphasia.

Eligibility Criteria

Inclusion Criteria

  • Veterans and non Veterans
  • Males or females
  • Stroke survivor who is at least 4 months post-stroke
  • Speaker of English since childhood
  • Ability to pass a pure-tone hearing screening (aided or unaided)
  • currently non-hospitalized
  • Age 21 to 90 years

Exclusion Criteria

  • neurological condition other than stroke
  • currently clinically depressed
  • history of speech/language problems prior to stroke
  • untreated psychopathology
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02332915). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search